- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00127751
Heart Disease on the Mend
August 24, 2005 updated by: Stanford University
A Cardiovascular Disease Multifactor Risk Reduction Program for Medically Underserved High-Risk Patients
The primary objective of this study was to evaluate the effectiveness of a multifactor cardiovascular disease (CVD) risk reduction program using team case management in high risk patients who have low family incomes and limited access to medical care.
Patients were randomized to case management (99) or usual care (49) with baseline, 6-month and 12-month evaluations of CVD risk factors, clinical status and quality of life.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The primary objective of this study was to evaluate the effectiveness of a multifactor cardiovascular disease (CVD) risk reduction program using team case management in high risk patients who have low family incomes and limited access to medical care.
Patients were randomized to case management (99) or usual care (49) with baseline, 6-month and 12-month evaluations of CVD risk factors, clinical status and quality of life.
Subjects were primarily recruited from patients being seen in free medical clinics in Santa Clara County California.
Primary eligibility was ≥ 35 years of age, one or more CVD risk factors (with or without clinical CVD), low family income, and residing in Santa Clara County.
Patients in the case management group were provided counseling services by specially trained registered nurses (RNs) and registered dieticians (RDs) and assisted in obtaining medications and medical services from programs provided in the county or indigent drug programs provided by selected pharmaceutical companies.
Protocol driven treatment algorithms based on national practice guidelines were used and use of existing programs and resources were maximized.
On average patients in case management were seen by staff 6-9 in the 12 months.
Study Type
Interventional
Enrollment
150
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
35 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Men and women ≥ 35 years
- One or more major risk factors
- Live in Santa Clara County
- Low family income that limits access to medical care
Exclusion Criteria:
- Under active medical treatment for cancer, CVD or other major medical disorder
- Reasonable access to health care
- Under 35 years of age
- Not a resident of Santa Clara County
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Cardiovascular disease risk score
|
|
Low-density lipoprotein (LDL)-cholesterol
|
|
Systolic blood pressure
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
Body mass index (BMI)
|
|
Physical activity score
|
|
Nutrition score
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: William L Haskell, PhD, Stanford University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2000
Study Completion
May 1, 2003
Study Registration Dates
First Submitted
August 5, 2005
First Submitted That Met QC Criteria
August 5, 2005
First Posted (ESTIMATE)
August 8, 2005
Study Record Updates
Last Update Posted (ESTIMATE)
August 25, 2005
Last Update Submitted That Met QC Criteria
August 24, 2005
Last Verified
August 1, 2005
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 373765
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on Enhance health lifestyle changes and medication compliance
-
Royal Marsden NHS Foundation TrustUnknownColo-rectal Cancer | Life Style
-
Cairo UniversityRecruiting
-
Ankara Yildirim Beyazıt UniversityCompleted
-
Tel-Aviv Sourasky Medical CenterKaMaH - The Center for Health-Promoting TherapiesRecruitingIndolent LymphomaIsrael
-
University of the Balearic IslandsNot yet recruiting
-
Herlev HospitalUniversity of Copenhagen; Association of Danish PhysiotherapistsActive, not recruiting
-
University of Illinois at Urbana-ChampaignActive, not recruitingOverweight and ObesityUnited States
-
University of North Carolina, Chapel HillCenters for Disease Control and PreventionCompletedCardiovascular Disease | Coronary Heart DiseaseUnited States
-
Institute of Cardiology, Warsaw, PolandUnknownCoronary Artery DiseasePoland
-
University of Illinois at ChicagoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed